Pharmaceutical News and Articles

Study Finds Redlined Neighborhoods Face Delays in Emergency Care

FRIDAY, Aug. 15, 2025 People living in neighborhoods once labeled hazardous on federal housing maps are still more likely to wait longer for an ambulance, new r

New Brain Implant Could Let People Speak Just by Thinking Words

FRIDAY, Aug. 15, 2025 For the first time, scientists have created a brain implant that can hear and vocalize words a person is only imagining in their head. The

Ladder Recall Follows Reports of Falls, Head Injuries and Broken Bones

FRIDAY, Aug. 15, 2025 More than 122,000 ladders sold at Home Depot are being recalled because their locking mechanism can fail, putting users at risk of a fall.

Hypoglossal Nerve Stimulator Implantation Safe for OSA in Children With Down Syndrome

For children aged younger than 13 years with Down syndrome (DS) and severe obstructive sleep apnea (OSA), hypoglossal nerve stimulator (HGNS) implantation is sa

Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors

Opportunistic pop-up community screening identifies a high prevalence of uncontrolled cardiovascular risk factors, according to a study published online Aug. 15

Autoimmune Diseases Linked to Digestive System Cancers

Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine. Julia Rei

High Metabolic Syndrome Severity Linked to Development of CKD

High metabolic syndrome (MetS) severity, expressed by the continuous metabolic syndrome severity score (cMetS-S), is associated with development of chronic kidn

FDA Approves Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the Treatment of Fibromyalgia

Centenarians Have Fewer Diseases, Develop Them More Slowly

Centenarians have lower overall disease burden, delayed onset of multiple conditions, and fewer cooccurring diseases over time, according to a study published o

Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint

CAMBRIDGE, Mass., August 13, 2025 Vedanta Biosciences, a late clinical-stage biopharmaceutical company developing microbiome-based oral therapies for gastrointe